samedan logo
 
 
 
spacer
home > pmps > autumn 2020 > rapid vaccine distribution to over 7.5 billion humans
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Rapid Vaccine Distribution to Over 7.5 Billion Humans

Who would have said a year ago that disruptions to supply chains, and more broadly, our way of life, would not come from a new company, a start-up, or a new economic model, but rather from a virus?

The disruption caused by COVID-19 has been extensive, we cannot control its spread, and we do not understand its behaviour. How it affects our health varies from person to person for unknown reasons, and may include mild symptoms, severe symptoms, or even asymptotic cases in individuals who spread the virus unknowingly.

The Race for a Vaccine is Underway

Over 193 vaccines are currently being trialled, 151 of which are in the pre-clinical phase, and over 42 of which have begun clinical trials (1). Over eight different types of vaccines are being trialled: messenger RNA (mRNA), DNA plasmid, protein subunit, adenovirus-vectored, measles-vectored, vesicular stomatitis virus-vectored, adenovirus associated-vectored, and inactivated virus vaccines.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Florence Lehec is Head of Marketing for EMBALL’ISO Group, its eight worldwide productions sites and 14 service hubs. Florence joined EMBALL’ISO three years ago. Besides her marketing and communication activities, she has worked on the development of the isothermal solution ‘reuse and reverse business model’ together with the sales team and the supply chain team. Before taking these responsibilities, she has held several sales and marketing positions for Air France. She is a graduate of ESSEC MBA, France.
spacer
Florence Lehec
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

A&M Cold Storage Rallies to Help Global COVID-19 Vaccine Distribution Efforts via Carrier Pods Unit Availability and Expanded Lynx Capabilities

PALM BEACH GARDENS, FLA., Dec. 14, 2020 – A&M Cold Storage recently responded to Carrier’s call to support global COVID-19 vaccine distribution efforts by making immediately available 90 Carrier Pods™ monitored by Sensitech® for deployment to help address the anticipated increase in demand for refrigerated storage capacity. Carrier and Sensitech are part of Carrier Global Corporation (NYSE: CARR), a leading global provider of healthy, safe and sustainable building and cold chain solutions.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement